Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

SHSSX vs DLHIX overlap: 44% of top holdings shared

Bottom line

How much do SHSSX and DLHIX overlap?

44% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 45.5% of SHSSX's assets and 39.0% of DLHIX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

SHSSXDLHIX
Weight overlap (top 25)44%
Shared holdings12
Weight in shared holdings45.5%39.0%
Total positions155108
Expense ratio0.86%0.96%
Holdings as ofMay 29, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods May 29, 2026 / Jun 30, 2026)

Holdings SHSSX and DLHIX have in common

Holding% of SHSSX% of DLHIXOverlap
Eli Lilly & Company LLY12.29%4.16%4.16%
Unitedhealth Group Inc UNH6.10%3.88%3.88%
Merck & Company Inc MRK4.94%3.68%3.68%
Gilead Sciences Inc GILD4.19%3.54%3.54%
Abbvie Inc ABBV3.94%4.19%3.94%
Amgen Inc AMGN3.37%2.27%2.27%
Vertex Pharmaceuticals Inc VRTX2.74%1.66%1.66%
Pfizer Inc PFE2.61%3.84%2.61%
Boston Scientific Corp BSX1.59%1.42%1.42%
Elevance Health Inc ELV1.56%3.25%1.56%
Astrazeneca Plc AZN1.21%3.27%1.21%
Regeneron Pharmaceuticals Inc REGN0.91%3.91%0.91%

Source: SEC Form N-PORT (periods May 29, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in SHSSX

  1. Johnson & Johnson — 8.77%
  2. Thermo Fisher Scientific Inc — 3.02%
  3. Edwards Lifesciences Corp — 2.51%
  4. Danaher Corp — 2.00%
  5. Abbott Laboratories — 1.97%
  6. Intuitive Surgical Inc — 1.95%
  7. Teva Pharmaceutical Industries Ltd — 1.87%
  8. Argenx Se — 1.26%
  9. Biogen Inc — 1.21%
  10. Stryker Corp — 1.15%
  11. Blackrock Funds III — 1.01%
  12. Revolution Medicines Inc — 0.96%
  13. Humana Inc — 0.92%

Only in DLHIX

  1. Ucb Sa — 5.19%
  2. Roche Holding Ag — 3.01%
  3. Chugai Pharmaceutical Co Ltd — 2.77%
  4. Viatris Inc — 2.48%
  5. Oruka Therapeutics Inc — 2.41%
  6. Halozyme Therapeutics Inc — 2.30%
  7. Illumina Inc — 2.11%
  8. Alkermes Plc — 1.82%
  9. Viking Therapeutics Inc — 1.72%
  10. Roivant Sciences Ltd — 1.60%
  11. Neurocrine Biosciences Inc — 1.57%
  12. Arcus Biosciences Inc — 1.56%
  13. Zimmer Biomet Holdings Inc — 1.42%

Asset mix

Asset typeSHSSXDLHIX
Stocks99.8%94.8%
Preferred stock—3.0%
Cash & short-term funds1.4%2.0%

Source: SEC Form N-PORT (periods May 29, 2026 / Jun 30, 2026)

Country mix

CountrySHSSXDLHIX
US93.9%75.4%
BE0.3%5.2%
GB1.4%3.3%
IE—3.2%
CH1.4%3.0%
JP0.2%2.8%
FR—2.0%
IL1.9%0.3%

Source: SEC Form N-PORT (periods May 29, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do SHSSX and DLHIX overlap?
About 44% by weight. 12 securities appear in both funds' top 25 holdings; they make up 45.5% of SHSSX's assets and 39.0% of DLHIX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do SHSSX and DLHIX have in common?
The largest shared holdings are Eli Lilly & Company, Abbvie Inc, Unitedhealth Group Inc, Merck & Company Inc, Gilead Sciences Inc.
Should I own both SHSSX and DLHIX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, SHSSX or DLHIX?
SHSSX is broader, with 155 positions versus 108 for DLHIX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.